MUMBAI: Ranbaxy Laboratories Ltd said on Friday it had received tentative approval from the US Food and Drug Administration to manufacture and market zolpidem tablets, used to treat insomnia.
MUMBAI: Ranbaxy Laboratories Ltd said on Friday it had received tentative approval from the US Food and Drug Administration to manufacture and market zolpidem tablets, used to treat insomnia.
Labels: Commercial use, Ranbaxy, Zolpidem